Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-207148

Chief Operating Officer sold 4,750 shares at an average $227.95 ($1,082,771)

  • Chief Operating Officer acquired 4,750 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jacobson Mark L. Chief Operating Officer 2026-05-04 Option exercise 10b5-1 +4,517 $12.95 $58,495 4,517 D
Jacobson Mark L. Chief Operating Officer 2026-05-04 Sale 10b5-1 −4,517 $227.94 $1,029,605 0 D
Jacobson Mark L. Chief Operating Officer 2026-05-05 Option exercise 10b5-1 +233 $12.95 $3,017 233 D
Jacobson Mark L. Chief Operating Officer 2026-05-05 Sale 10b5-1 −233 $228.18 $53,166 0 D
Derivatives
Jacobson Mark L. Chief Operating Officer 2026-05-04 Option exercise · Stock Option (Right to Buy) 10b5-1 −4,517 115,187 D
Jacobson Mark L. Chief Operating Officer 2026-05-05 Option exercise · Stock Option (Right to Buy) 10b5-1 −233 114,954 D
Open-market sales · 4,750 sh · avg $227.95 · $1,082,771
Loading xslF345X06/ownership.xml…